Skip to content

Construction of a prognostic clinical prediction model for late-stage non-small cell lung cancer integrating traditional Chinese and Western medicine.

Construction of a prognostic clinical prediction model for late-stage non-small cell lung cancer integrating traditional Chinese and Western medicine.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025002635
Enrollment
Unknown
Registered
2025-12-30
Start date
2025-07-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced non-small cell lung cancer

Interventions

Observation group:The traditional Chinese medical treatments received during the observation period must include, but are not limited to, Chinese herbal medicine taken internally, external TCM therapi

Sponsors

China Academy of Traditional Chinese Medicine Wangjing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Age = 18 years, gender; (2) Pathological tissue examination results show non-small cell lung cancer; (3) At the time of enrollment, imaging examination confirms Stage IV, including those who have not undergone curative surgery and those with recurrence or metastasis after surgery; (4) The traditional Chinese medicine (TCM) treatments received during the observation period must include, but are not limited to, oral Chinese medicine, external TCM therapies, and Chinese patent medicines.

Exclusion criteria

Exclusion criteria: The primary lesion is not in the lung.

Design outcomes

Primary

MeasureTime frame
Overall Survival (OS);Progression-Free Survival (PFS);Quality of life;Evaluation Criteria for Traditional Chinese Medicine Syndromes;Solid Tumor Efficacy Evaluation;Time to Improvement of Individual Symptoms;

Countries

China

Contacts

Public ContactZhang Ming

China Academy of Traditional Chinese Medicine Wangjing Hospital

zyyzhangming@163.com18519242319

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026